[Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors]. - Suppr | 超能文献

[Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].

作者信息

Ruibal A, Arias J I

出版信息

Rev Esp Med Nucl. 2002 Nov-Dec;21(6):437-8. doi: 10.1016/s0212-6982(02)72122-8.

DOI:10.1016/s0212-6982(02)72122-8

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].

Rev Esp Med Nucl. 2002 Nov-Dec;21(6):437-8. doi: 10.1016/s0212-6982(02)72122-8.

2

[Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].[乳腺雌激素受体阳性和孕激素受体阳性浸润性导管癌中的细胞溶质pS2水平与细胞增殖]

Rev Esp Med Nucl. 2005 May-Jun;24(3):185-90. doi: 10.1157/13073789.

3

[Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].雌激素受体浓度>300 fmol/mg蛋白质的乳腺浸润性导管癌的临床生物学特征

Rev Esp Med Nucl. 2001 Oct;20(6):503-5. doi: 10.1016/s0212-6982(01)71998-2.

4

[Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].[乳腺浸润性导管癌中组织多肽特异性（TPS）抗原胞浆浓度的研究。与激素依赖性呈正相关，与细胞增殖呈负相关]

Rev Esp Med Nucl. 2001 Aug;20(5):365-8. doi: 10.1016/s0212-6982(01)71975-1.

5

[Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].[绝经后女性118例雌激素受体阳性乳腺浸润性导管癌中孕激素受体状态的临床生物学意义]

Rev Esp Med Nucl. 2000 Jun;19(3):244-6.

6

[Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations].[60岁以上女性乳腺浸润性导管癌。与较高的细胞增殖及较低的PS2、细胞表面和胞质透明质酸浓度的关联]

Rev Esp Med Nucl. 2001 Dec;20(7):525-9. doi: 10.1016/s0212-6982(01)72007-1.

7

pS2 negativity in postmenopausal women with ER+PgR+ infiltrating ductal breast carcinoma is associated with reduced hormone dependence and increased proliferation and aneuploidy of the tumors.

Int J Biol Markers. 1999 Jul-Sep;14(3):186-8. doi: 10.1177/172460089901400311.

8

[Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters].

Rev Esp Med Nucl. 2001 Jun;20(4):332-3. doi: 10.1016/s0212-6982(01)71967-2.

9

Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas.浸润性导管乳腺癌中的雌激素受体、孕激素受体、pS2、ERD5、热休克蛋白27和组织蛋白酶D

Histopathology. 1993 Sep;23(3):239-48. doi: 10.1111/j.1365-2559.1993.tb01196.x.

10

HER2 as a prognostic factor in breast cancer.HER2作为乳腺癌的一个预后因素。

Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404.